GLP-1 Drugs Influence Diets of Over One in Five Adults in the Americas, Research Shows
A study by Dunnhumby reveals that GLP-1 medications are actively shaping what more than 20% of adults across the Americas eat and drink.
According to research conducted by Dunnhumby, GLP-1 drugs are influencing what more than one in five adults across the Americas eat and drink.
The findings point to a notable shift in consumer behavior across the region. As GLP-1 treatments affect the dietary choices of a significant share of the adult population, understanding these evolving consumption patterns becomes critical for beverage companies monitoring shifting market demand.
Key facts
- Research by Dunnhumby shows GLP-1 drugs influence what more than one in five adults across the Americas eat and drink.
Why it matters
Understanding how GLP-1 drugs alter eating and drinking habits helps beverage companies anticipate shifting consumer demand and adapt product offerings in the Americas.
- Just Drinks — 2026-11-18: “GLP-1s shape diets of one in five adults in Americas, study shows”
This article was prepared by WBI.org from the sources listed above with the assistance of AI and reviewed by a WBI editor before publication. Information is attributed to its original sources.